Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Navidea Biopharmaceuticals Inc (NYSE MKT LLC:NAVB)

0.45
Delayed Data
As of May 26
 +0.0065 / +1.47%
Today’s Change
0.26
Today|||52-Week Range
1.16
-29.41%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
AssetsCash32.9M5.5M7.2M6.5M
 
 
 
 
 
Short Term Investment Cash23.8M-27.5M1.7M-625.7K
 
 
 
 
 
Cash & Short Term Investments32.9M5.5M7.2M6.5M
 
 
 
 
 
 
ReceivablesReceivables1.2M816.5K3.7M1.8M
 
 
 
 
 
 
InventoriesInventories2.2M932.4K652.9K1.5M
 
 
 
 
 
 
Current AssetsOther Current Assets1.0M1.4M1.1M1.0M
 
 
 
 
 
Current Assets37.3M8.6M12.6M10.8M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross3.6M4.1M3.9M3.6M
 
 
 
 
 
Depreciation-1.5M-1.6M-1.9M-2.3M
 
 
 
 
 
Intangible Assets136.9K180.8K186.2K181.0K
 
 
 
 
 
Other Assets860.0K569.8K459.7K383.8K
 
 
 
 
 
Total Assets40.3M11.9M15.0M12.5M
 
 
 
 
 
 
LiabilitiesAccounts Payable2.4M1.5M1.8M7.1M
 
 
 
 
 
Short Term Debt4.1M4.4M333.3K52.0M
 
 
 
 
 
Accrued Expenses3.4M2.0M2.2M1.8M
 
 
 
 
 
Other Current Liabilities3.6M2.3M3.2M9.8M
 
 
 
 
 
Other Liabilities11.3M9.1M6.2M69.9M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt23.6M29.5M60.7M9.6M
 
 
 
 
 
Other Liabilities9.5M3.1M1.7M598.9K
 
 
 
 
 
Total Liabilities44.3M41.7M68.8M80.1M
 
 
 
 
 
 
EquityMinority Interest0.000.00-855.00-648.00
 
 
 
Preferred Stock8.004.000.000.00
 
 
 
Common Equity-4.0M-29.8M-54.3M-68.1M
 
 
 
 
 
Total Shareholder Equity-4.0M-29.8M-54.3M-68.1M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding135.9M150.2M155.6M155.8M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.